Skip to main content

Advertisement

SpringerLink
Log in

Epigenetics and Systemic Lupus Erythematosus: Unmet Needs

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is a chronic relapsing–remitting autoimmune disease affecting several organs. Although the management of lupus patients has improved in the last years, several aspects still remain challenging. More sensitive and specific biomarkers for an early diagnosis as well as for monitoring disease activity and tissue damage are needed. Genome-wide association and gene mapping studies have supported the genetic background for SLE susceptibility. However, the relatively modest risk association and the studies in twins have suggested a role for environmental and epigenetic factors, as well as genetic–epigenetic interaction. Accordingly, there is evidence that differences in DNA methylation, histone modifications, and miRNA profiling can be found in lupus patients versus normal subjects. Moreover, impaired DNA methylation on the inactive X-chromosome was suggested to explain, at least in part, the female prevalence of the disease. Epigenetic markers may be help in fulfilling the unmet needs for SLE by offering new diagnostic tools, new biomarkers for monitoring disease activity, or to better characterize patients with a silent clinical disease but with an active serology. Anti-DNA, anti-phospholipid, and anti-Ro/SSA autoantibodies are thought to be pathogenic for glomerulonephritis, recurrent thrombosis and miscarriages, and neonatal lupus, respectively. However, tissue damage occurs occasionally or, in some patients, only in spite of the persistent presence of the antibodies. Preliminary studies suggest that epigenetic mechanisms may explain why the damage takes place in some patients only or at a given time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Deng Y, Tsao BP (2014) Advances in lupus genetics and epigenetics. Curr Opin Rheumatol 26:482–492

    Article  PubMed  PubMed Central  Google Scholar 

  2. Marion TN, Postlethwaite AE (2014) Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus. Semin Immunopathol 36:495–517

    Article  CAS  PubMed  Google Scholar 

  3. Mohan C, Putterman C (2015) Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol 11:329–341

    Article  CAS  PubMed  Google Scholar 

  4. Costa-Reis P, Sullivan KE (2013) Genetics and epigenetics of systemic lupus erythematosus. Curr Rheumatol Rep 15:369

    Article  PubMed  Google Scholar 

  5. Connolly JJ, Hakonarson H (2012) Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing. J Biomed Biotechnol 2012:798924

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cui Y, Sheng Y, Zhang X (2013) Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun 41:25–33

    Article  CAS  PubMed  Google Scholar 

  7. Coit P, Jeffries M, Altorok N et al (2013) Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J Autoimmun 43:78–84

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sawalha AH, Jeffries M, Webb R et al (2008) Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun 9:368–378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B (1988) Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 140:2197–2200

    CAS  PubMed  Google Scholar 

  10. Deng C, Lu Q, Zhang Z et al (2003) Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 48:746–756

    Article  CAS  PubMed  Google Scholar 

  11. Lieberman MW, Beach LR, Palmiter RD (1983) Ultraviolet radiation-induced metallothionein-I gene activation is associated with extensive DNA demethylation. Cell 35:207–214

    Article  CAS  PubMed  Google Scholar 

  12. Quddus J, Johnson KJ, Gavalchin J et al (1993) Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 92:38–53

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhang Y, Zhao M, Sawalha AH, Richardson B, Lu Q (2013) Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. J Autoimmun 41:92–99

    Article  PubMed  Google Scholar 

  14. Hedrich CM, Tsokos GC (2011) Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol Med 17:714–724

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Javierre BM, Richardson B (2011) A new epigenetic challenge: systemic lupus erythematosus. Adv Exp Med Biol 711:117–136

    Article  CAS  PubMed  Google Scholar 

  16. Javierre BM, Fernandez AF, Richter J et al (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 20:170–179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Qin HH, Zhu XH, Liang J et al (2013) Associations between aberrant DNA methylation and transcript levels of DNMT1 and MBD2 in CD4 + T cells from patients with systemic lupus erythematosus. Australas J Dermatol 54:90–95

    Article  PubMed  Google Scholar 

  18. Zhu X, Liang J, Li F, Yang Y, Xiang L, Xu J (2011) Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus. Int J Dermatol 50:697–704

    Article  CAS  PubMed  Google Scholar 

  19. Zhang Z, Song L, Maurer K, Petri MA, Sullivan KE (2010) Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes. Genes Immun 11:124–133

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hedrich CM, Rauen T, Kis-Toth K, Kyttaris VC, Tsokos GC (2012) cAMP-responsive element modulator alpha (CREMalpha) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE). J Biol Chem 287:4715–4725

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rauen T, Hedrich CM, Juang YT, Tenbrock K, Tsokos GC (2011) cAMP-responsive element modulator (CREM)alpha protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus. J Biol Chem 286:43437–43446

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ceribelli A, Satoh M, Chan EK (2012) MicroRNAs and autoimmunity. Curr Opin Immunol 24:686–691

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Deng X, Su Y, Wu H et al (2015) The role of microRNAs in autoimmune diseases with skin involvement. Scand J Immunol 81:153–165

    Article  CAS  PubMed  Google Scholar 

  24. Liu A, La Cava A (2014) Epigenetic dysregulation in systemic lupus erythematosus. Autoimmunity 47:215–219

    Article  PubMed  Google Scholar 

  25. Miao CG, Yang YY, He X et al (2013) The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell Signal 25:1828–1836

    Article  CAS  PubMed  Google Scholar 

  26. Yan S, Yim LY, Lu L, Lau CS, Chan VS (2014) MicroRNA regulation in systemic lupus erythematosus pathogenesis. Immune Netw 14:138–148

    Article  PubMed  PubMed Central  Google Scholar 

  27. Zhao M, Liu S, Luo S et al (2014) DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun 54:127–136

    Article  CAS  PubMed  Google Scholar 

  28. Richardson BC, Patel DR (2014) Epigenetics in 2013. DNA methylation and miRNA: key roles in systemic autoimmunity. Nat Rev Rheumatol 10:72–74

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Pan W, Zhu S, Yuan M et al (2010) MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184:6773–6781

    Article  CAS  PubMed  Google Scholar 

  30. Zhao S, Wang Y, Liang Y et al (2011) MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 63:1376–1386

    Article  CAS  PubMed  Google Scholar 

  31. Tang Y, Luo X, Cui H et al (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60:1065–1075

    Article  CAS  PubMed  Google Scholar 

  32. Carlsen AL, Schetter AJ, Nielsen CT et al (2013) Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 65:1324–1334

    Article  CAS  PubMed  Google Scholar 

  33. Lu J, Kwan BC, Lai FM et al (2012) Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton 17:346–351

    Article  CAS  Google Scholar 

  34. Stagakis E, Bertsias G, Verginis P et al (2011) Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 70:1496–1506

    Article  CAS  PubMed  Google Scholar 

  35. Te JL, Dozmorov IM, Guthridge JM et al (2010) Identification of unique microRNA signature associated with lupus nephritis. PLoS One 5:e10344

    Article  PubMed  PubMed Central  Google Scholar 

  36. Thai TH, Patterson HC, Pham DH, Kis-Toth K, Kaminski DA, Tsokos GC (2013) Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse. Proc Natl Acad Sci U S A 110:20194–20199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Wang G, Tam LS, Kwan BC et al (2012) Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin Rheumatol 31:435–440

    Article  PubMed  Google Scholar 

  38. Wen Z, Xu L, Chen X et al (2013) Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway. J Immunol 190:5411–5422

    Article  CAS  PubMed  Google Scholar 

  39. Altorok N, Sawalha AH (2013) Epigenetics in the pathogenesis of systemic lupus erythematosus. Curr Opin Rheumatol 25:569–576

    Article  CAS  PubMed  Google Scholar 

  40. Coit P, Renauer P, Jeffries M A, et al (2015) Renal involvement in lupus is characterized by unique DNA methylation changes in naive CD4+ T cells. J Autoimmun

  41. Coit P, Yalavarthi S, Ognenovski M et al (2015) Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils. J Autoimmun 58:59–66

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Rauen T, Hedrich CM, Tenbrock K, Tsokos GC (2013) cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol Med 19:262–269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Hughes GC, Choubey D (2014) Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat Rev Rheumatol 10:740–751

    Article  CAS  PubMed  Google Scholar 

  44. Schwartzman-Morris J, Putterman C (2012) Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol 2012:604892

    Article  PubMed  PubMed Central  Google Scholar 

  45. Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B (2007) Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 179:6352–6358

    Article  CAS  PubMed  Google Scholar 

  46. Scofield RH, Bruner GR, Namjou B et al (2008) Klinefelter’s syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58:2511–2517

    Article  PubMed  PubMed Central  Google Scholar 

  47. Lateef A, Petri M (2012) Unmet medical needs in systemic lupus erythematosus. Arthritis Res Ther 14(Suppl 4):S4

    Article  PubMed  PubMed Central  Google Scholar 

  48. Illei GG, Tackey E, Lapteva L, Lipsky PE (2004) Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum 50:2048–2065

    Article  CAS  PubMed  Google Scholar 

  49. Gladman DD, Hirani N, Ibanez D, Urowitz MB (2003) Clinically active serologically quiescent systemic lupus erythematosus. J Rheumatol 30:1960–1962

    PubMed  Google Scholar 

  50. Steiman AJ, Gladman DD, Ibanez D, Urowitz MB (2010) Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome. J Rheumatol 37:1822–1827

    Article  PubMed  Google Scholar 

  51. Cornec D, Jamin C, Pers JO (2014) Sjogren’s syndrome: where do we stand, and where shall we go? J Autoimmun 51:109–114

    Article  PubMed  Google Scholar 

  52. Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161–167

    Article  CAS  PubMed  Google Scholar 

  53. Pillai S (2013) Rethinking mechanisms of autoimmune pathogenesis. J Autoimmun 45:97–103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Lu Q (2013) The critical importance of epigenetics in autoimmunity. J Autoimmun 41:1–5

    Article  PubMed  Google Scholar 

  55. Zhang P, Zhao M, Liang G et al (2013) Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. J Autoimmun 41:17–24

    Article  PubMed  Google Scholar 

  56. Javierre BM, Hernando H, Ballestar E (2011) Environmental triggers and epigenetic deregulation in autoimmune disease. Discov Med 12:535–545

    PubMed  Google Scholar 

  57. Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358:929–939

    Article  CAS  PubMed  Google Scholar 

  58. Seredkina N, Van Der Vlag J, Berden J, Mortensen E, Rekvig OP (2013) Lupus nephritis: enigmas, conflicting models and an emerging concept. Mol Med 19:161–169

    Article  PubMed  PubMed Central  Google Scholar 

  59. Freedman BI, Langefeld CD, Andringa KK et al (2014) End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol 66:390–396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Lin CP, Adrianto I, Lessard CJ et al (2012) Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun 13:232–238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Reeves-Daniel AM, DePalma JA, Bleyer AJ et al (2011) The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 11:1025–1030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Thiyagarajan D, Fismen S, Seredkina N et al (2012) Silencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin fragments and activation of Toll like receptors and the Clec4e. PLoS One 7:e34080

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Ben David D, Reznick AZ, Srouji S, Livne E (2008) Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors. Histochem Cell Biol 129:589–597

    Article  CAS  PubMed  Google Scholar 

  64. Lim EJ, Lee SH, Lee JG et al (2006) Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling. FEBS Lett 580:4533–4538

    Article  CAS  PubMed  Google Scholar 

  65. Merrell MA, Ilvesaro JM, Lehtonen N et al (2006) Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 4:437–447

    Article  CAS  PubMed  Google Scholar 

  66. Shearwin KE, Callen BP, Egan JB (2005) Transcriptional interference—a crash course. Trends Genet 21:339–345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Chafin CB, Reilly CM (2013) MicroRNAs implicated in the immunopathogenesis of lupus nephritis. Clin Dev Immunol 2013:430239

    Article  PubMed  PubMed Central  Google Scholar 

  68. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y (2009) Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29:749–754

    Article  CAS  PubMed  Google Scholar 

  69. Meroni PL, Chighizola CB, Rovelli F, Gerosa M (2014) Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Res Ther 16:209

    Article  PubMed  PubMed Central  Google Scholar 

  70. Meroni PL, Borghi MO, Raschi E, Tedesco F (2011) Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 7:330–339

    Article  CAS  PubMed  Google Scholar 

  71. Agostinis C, Biffi S, Garrovo C et al (2011) In vivo distribution of beta2 glycoprotein I under various pathophysiologic conditions. Blood 118:4231–4238

    Article  CAS  PubMed  Google Scholar 

  72. Raschi E, Chighizola CB, Grossi C et al (2014) beta2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis. J Autoimmun 55:42–50

    Article  CAS  PubMed  Google Scholar 

  73. Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368:1033–1044

    Article  CAS  PubMed  Google Scholar 

  74. Teruel R, Perez-Sanchez C, Corral J et al (2011) Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. J Thromb Haemost 9:1985–1992

    Article  CAS  PubMed  Google Scholar 

  75. Bazzoni F, Rossato M, Fabbri M et al (2009) Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A 106:5282–5287

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Rivera TL, Izmirly PM, Birnbaum BK et al (2009) Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Ann Rheum Dis 68:828–835

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Izmirly PM, Buyon JP, Saxena A (2012) Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease. Curr Opin Rheumatol 24:466–472

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Clancy RM, Buyon JP, Ikeda K et al (2005) Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum 52:3079–3086

    Article  CAS  PubMed  Google Scholar 

  79. Scarsi M, Radice A, Pregnolato F et al (2014) Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the ‘Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group’. Clin Exp Rheumatol 32:848–854

    PubMed  Google Scholar 

  80. Lindop R, Arentz G, Thurgood LA, Reed JH, Jackson MW, Gordon TP (2012) Pathogenicity and proteomic signatures of autoantibodies to Ro and La. Immunol Cell Biol 90:304–309

    Article  CAS  PubMed  Google Scholar 

  81. Clancy RM, Backer CB, Yin X et al (2004) Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor alpha: implications for pathogenesis. Arthritis Rheum 50:2598–2603

    Article  CAS  PubMed  Google Scholar 

  82. Clancy RM, Marion MC, Kaufman KM et al (2010) Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. Arthritis Rheum 62:3415–3424

    Article  PubMed  PubMed Central  Google Scholar 

  83. Siren MK, Julkunen H, Kaaja R, Ekblad H, Koskimies S (1999) Role of HLA in congenital heart block: susceptibility alleles in children. Lupus 8:60–67

    Article  CAS  PubMed  Google Scholar 

  84. Cimaz R, Borghi MO, Gerosa M, Biggioggero M, Raschi E, Meroni PL (2006) Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block: lesson from twins and triplets discordant for the disease. Arthritis Rheum 54:356–359

    Article  CAS  PubMed  Google Scholar 

  85. Ramos PS, Marion MC, Langefeld CD, International Consortium on Systemic Lupus Erythematosus Genetics, Buyon JP, Clancy RM (2012) Brief report: enrichment of associations in genes with fibrosis, apoptosis, and innate immunity functions with cardiac manifestations of neonatal lupus. Arthritis Rheum 64:4060–4065

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Stevens AM, Hermes HM, Rutledge JC, Buyon JP, Nelson JL (2003) Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 362:1617–1623

    Article  PubMed  Google Scholar 

  87. Stevens AM, Hermes HM, Lambert NC, Nelson JL, Meroni PL, Cimaz R (2005) Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block. Rheumatology (Oxford) 44:187–191

    Article  CAS  Google Scholar 

  88. Fesslova V, Mannarino S, Salice P et al (2003) Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets. Lupus 12:775–778

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto Auxologico Italiano, Milan, Italy

    Pier Luigi Meroni

  2. Division of Rheumatology, Istituto G. Pini, Piazza C. Ferrari, 1, 20122, Milan, Italy

    Pier Luigi Meroni & Alessandra Emiliana Penatti

  3. Department of Clinical Sciences and Health Community, University of Milan, Milan, Italy

    Pier Luigi Meroni & Alessandra Emiliana Penatti

Authors
  1. Pier Luigi Meroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandra Emiliana Penatti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pier Luigi Meroni.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meroni, P.L., Penatti, A.E. Epigenetics and Systemic Lupus Erythematosus: Unmet Needs. Clinic Rev Allerg Immunol 50, 367–376 (2016). https://doi.org/10.1007/s12016-015-8497-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-015-8497-4

Keywords

Search

Navigation